Disease Info Card

Myopathy, Idiopathic Inflammatory

Information about Myopathy, Idiopathic Inflammatory: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Myopathy, Idiopathic Inflammatory

Most recent studies have shown that Myopathy, Idiopathic Inflammatory shares some biological mechanisms with arthritis, autoimmune-diseases, autoimmune-reaction, connective-tissue-diseases, dermatomyositis, dermatomyositis-childhood-type, inclusion-body-myopathy-sporadic, inclusion-body-myositis-(disorder), inflammation, lung-diseases, lung-diseases-interstitial, lupus-erythematosus-systemic, malignant-neoplasms, muscle-weakness, myopathy, myositis, neoplasms, polymyositis, pulmonary-fibrosis, weakness.

Among the many pathways, these few ones have gauged particular interests from scientists studying Myopathy, Idiopathic Inflammatory, and have been seen in publications frequently: Aging, Cell Activation, Cell Adhesion, Cell Cycle, Cell Death, Cell Migration, Chemokine Production, Complement Activation, Cytokine Production, Diapedesis, Immune Response, Inflammatory Response, Localization, Lymphocyte Activation, Muscle Atrophy, Pathogenesis, Regeneration, Secretion, T Cell Activation, Transport

Quite a number of genes have been found to play important roles in Myopathy, Idiopathic Inflammatory, such as CCL2, CD4, CD8A, CHKA, CHKB, CTLA4, DMPK, EXOSC10, HLA-DQA1, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, IFNG, IL1RN, NOD2, PRB1, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.